Delhi HC sets aside govt ban on Lupin FDC, refers matter back to Drug Board

Govt had in September 2018 banned 344 FDC drugs, including Lupin's combo for diabetics, citing lack of therapeutic justification

The Delhi High Court on Wednesday set aside the central government’s ban on Lupin’s fixed dose combination drug (FDC) Gluconorm-PG 1 Forte and Gluconorm-PG 2 Forte and remanded the matter back to Drug Technical Advisory Board (DTAB) for further consideration on the issue. A detailed copy of the order is awaited.

The drug, used for treatment of patients suffering from Type 2 diabetes, was banned by the central government vide a notification issued on September 7, 2018. Exercising its powers under Section 26A of the Drugs and Cosmetics Act, 1940 (Drugs Act), the government had prohibited the manufacture, sale and